Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin versus oral antihyperglycemic drugs for glycemic control and hypoglycemia in type 2 diabetes
ChiCTR1900022073Phase 4Recruiting
- Sponsor
- Nanjing Hospital of Integrated Traditional Chinese and Western Medicine
- Start
- Mar 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of human insulin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Nanjing Hospital of Integrated Traditional Chinese and Western Medicine. Primary endpoint: Rate of hypoglycemia. Started Mar 2019; status: recruiting.
02
Drugs
human insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR1900022073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022073.